期刊文献+

乳腺癌细胞共激活因子SRC-1的表达变化与内分泌治疗的关系

Expression changes of SRC-1 in breast cancer cells and its relationship with endocirine therapy
下载PDF
导出
摘要 目的:观察三苯氧胺作用前后ERα阳性细胞株T-47D和ERα阴性细胞株MDA-MB-231中共激活因子SRC-1的表达变化,研究共激活因子与内分泌治疗的内在关系。方法:四氮甲唑蓝(MTT)观察两细胞的生存状况,以筛选最佳的药物作用浓度和时间。单细胞凝胶电泳法(Comet法)检测细胞凋亡。细胞免疫组化法观察TAM作用前后细胞中ERα和SRC-1的表达情况。Western blot法检测TAM作用前后细胞中ERα和SRC-1的表达水平变化情况。结果:MTT法测得TAM作用后T-47D和MDA-MB-231的OD值下降,与对照组相比有显著性差异(P<0.05),对T-47D效果更强。0.10mmol/L TAM作用48 h后两种细胞的活力均出现最低值。单细胞凝胶电泳法观察到TAM作用后两组细胞均发生凋亡、染色体断裂现象,尾长、尾DNA%、尾矩、Olive尾矩等指标在给药组与对照组之间有显著性差异,T-47D与MDA-MB-231组相比也有显著性差异(P<0.05)。细胞免疫组化法检测T-47D细胞在TAM作用后ERα阳性细胞减少,SRC-1在作用前后均为阴性;MDA-MB-231细胞SRC-1表达阳性,TAM作用后,SRC-1阳性细胞比例上调,ERα仍为阴性。Western blot结果显示TAM作用后,T-47D细胞ERα表达水平略有下降,SRC-1表达水平未见改变;MDA-MB-231细胞SRC-1表达水平略有升高,ERα表达水平未见改变。结论:在ERα阴性细胞株MDA-MB-231中,共激活因子SRC-1有较高水平表达。0.10mmol/L TAM作用于乳腺癌细胞MDA-MB-231 48 h后SRC-1表达轻微上调,此变化可不依赖于ERα的表达。 Objective:To observe the expression of eo - activator SRC - 1 in the ERa - positive and - negative cell strains before and after using tamoxifen and to study the internal relationship between SRC - 1 and endocrine therapy. Methods: MMT assay was adopted to test OD values of T47D cell strain and MDA - MB -231 cell strain before and after using tamoxifen in order to choose the most appropriate dosage and time of tamoxifen for later re- search. Comet assay was applied to analyze cell apoptosis after tamoxifen administration. Immunohistoehemistry was used to test expression alterations of SRC -1 in T-47D and MDA -MB -231 cell strains with and without tamox- ifen. Expression levels of ERa and SRC - 1 before and after using TAM were evaluated by Western blot. Results: OD values of T-47D and MDA-MB-231 decreased after using tmnoxifen and both had significant differences com-pared to the control group (P 〈0.05) , especially to the Etlot-positive cell strain T47D. The lowest OD value ap-peared after using 0.10 mmol/L tamoxifen for 48 h. Cell apoptosis and DNA fi'agments were observed by Comet as- say. Tail length, tale DNA% , tail moment and Olive moment had significant differences between tamoxifen group and control group, as well as that between T - 47D group and MDA - MB - 231 group( P 〈 0.05 ). The result of immuno-histoeheinistry showd that in T-47D cell strain, after TAM administration, the ratio of ERα positive cells deereaed, and the expression of SRC -1 were both negative. In MDA-MB -231 cell strain, the ratio of SllC -1 positive cells increased slightly, and the expression of ERα were both negative. Western blot indicated that in T -47D cell strain, the expression level of ERa deeresed, and the level of SRC -1 had no change. Meanwhile in MDA-MB-231 cell strain, the expression level of ERa had no moderation, but the level of SRC - 1 increased slightly after TAM affec-tion. Conclusion: In ERa negative MDA - MB -231 cell strain, the eo - activator SRC - 1 had high expression lev-el, after 0.10mmol/L TAM affecting on MDA - MB - 231 cells for 48h, the expression of-SRC - 1 turned from nega-tive to + , which had no relationship with ERα expression.
出处 《现代肿瘤医学》 CAS 2012年第9期1799-1804,共6页 Journal of Modern Oncology
关键词 三苯氧胺 乳腺癌 类固醇受体共刺激因子-1 雌激素受体Α tamoxifen breast cancer SRC-1 Era
  • 相关文献

参考文献13

  • 1Klinge CM. Estrogen receptor interaction with co - activators and co - repressoRS [ J ]. Steroids,2000, 65 ( 5 ) : 227 - 251.
  • 2Sauve F, McBroom LD, Gallant J, et al. CIA, a nove1 estrogen receptor coactivator with a bifunctional nuclear recptor interacting detenninant[J]. Mol Cell Bioi, 2001,21(1): 343 -353.
  • 3Fleming FJ, Myers E, Kelly G, et aJ. Expression of SRC - I , AIBI, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC - 1 [J]. J Clin Pathol , 2004, 57 (10): 1069-1074.
  • 4Uchikawa J, Shiozawa T, Shih HC, et al. Expression of steroid receptor coactivators and corepressors in human endometrial hyper- plasia and carcinoma with relevance to steroid receptors and Ki - 67 expression [J].Cancer, 2003, 98 (10) : 2207 - 2213.
  • 5许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 6Aranda A, Pascual A. Nuclear hormone receptors and gene expres- sion [J]. PhysiolRes, 2001, 81 (3): 1269-1304.
  • 7Fleming FJ, Hill ADK, McDermott EW, et al. Differential recruit- ment of co - regulator proteins SRC - 1 and SMRT to the estrogen receptor - estrogen response element by beta - estradiol and 4 - hydroxytamoxifen in human breast cancer [ J ]. J Clin Endocrinol Metab, 2004, 89:375 - 383.
  • 8Jacobs E, Bulpitt P, Coutts I, et al. New cahnodulin antagonists inhibit in vitro growth of human breast cancer cell lines independ- ent of their estrogen receptor status [J]. Anti - Cancer Drugs, 2000, 11 (2) :63 -68.
  • 9Berns EM, Van Staveren 1L, Klijn JG, et al. Predictive value ofSRC - 1 for tamoxifen response of recurrent breast cancer[J]. Breast Cancer Res Treat, 1998, 48:87 -92.
  • 10McCartan D, Bolger JC, Fagan A, et al. Global characterization of the SRC - 1 transcriptome identifies ADAM22 as an ER - inde- pendent mediator of endocrine - resistant breast cancer [ J ]. Cancer Res, 2012, 72 ( 1 ) : 220 - 229.

二级参考文献3

共引文献1367

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部